Abstract
We present a case of systemic lupus erythematosus complicated by pancytopenia and visceral leishmaniasis in Spain. The literature on opportunistic infection in lupus erythematosus is reviewed.Leishmaniasis is a group of infections caused by the protozoa Leishmania, which is endemic in the Mediterranean basin. These opportunistic infections are an emerging entity in immunosuppressed patients. The use of immunosuppressive treatment in systemic lupus erythematosus modifies natural defense patterns and increases the risk of visceral leishmaniasis in endemic areas.
MeSH terms
-
Adult
-
Amphotericin B / administration & dosage
-
Amphotericin B / therapeutic use
-
Antiprotozoal Agents / administration & dosage
-
Antiprotozoal Agents / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Immunosuppression Therapy / adverse effects
-
Leishmaniasis, Visceral / diagnosis
-
Leishmaniasis, Visceral / drug therapy
-
Leishmaniasis, Visceral / etiology*
-
Lupus Erythematosus, Systemic / complications*
-
Lupus Erythematosus, Systemic / drug therapy
-
Lupus Erythematosus, Systemic / immunology
-
Pancytopenia / etiology
-
Time Factors
Substances
-
Antiprotozoal Agents
-
Amphotericin B